"At UCSF Health, we're taking every precaution to keep you safe and healthy during the COVID-19 pandemic. For our outpatients, we offer video visits and virtual care for hundreds of conditions as well as for primary care, mental health services, medication monitoring and more. In our hospitals, we test every patient admitted and before most procedures. Our staff wears face masks and practices rigorous hand hygiene, as well as many other methods of infection prevention. Before entering your room, they'll make sure you're masked and (in UCSF Benioff Children's Hospitals) that your child age 2+ is masked. If you're planning to visit someone in the hospital, be sure to check our COVID-19 visitor restrictions before going."

During the past decade, UCSF Psoriasis and Skin Treatment Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Psoriasis and Skin Treatment Center" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "National Psoriasis Foundation" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Psoriasis and Skin Treatment Center" are "Psoriasis" (6 trials), "Atopic Dermatitis" (3 trials), "Eczema" (3 trials), "Atopic Dermatitis Eczema" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "UCSF Psoriasis and Skin Treatment Center" in a lesser frequency.

Most popular intervention types in "UCSF Psoriasis and Skin Treatment Center" are "Drug" (13 trials), "Device" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dupilumab" (2 trials), "Clobex Spray" (1 trials), "Crude Coal Tar Only" (1 trials), "Excimer Laser" (1 trials) and "Excimer laser phototherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Psoriasis and Skin Treatment Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Psoriasis and Skin Treatment Center". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in UCSF Psoriasis and Skin Treatment Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Psoriasis and Skin Treatment Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 5 trials that are defined as “Not Applicable".